Literature DB >> 234237

Interaction of glipizide with human serum albumin.

M J Crooks, K F Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 234237     DOI： 10.1016/0006-2952(75)90294-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

Review 1.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 2.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

Review 4.  Oral antidiabetic drug use in the elderly.

Authors:  R Bressler; D G Johnson
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

5.  Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics.

Authors:  E Wåhlin-Boll; L O Almér; A Melander
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 6.  Glipizide: a review of its pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

Review 7.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.